trimetazidine dihydrochloride Tablets, modified release (MR) 35 mg

It is one of the most rapidly expanding pharmaceutical enterprises in Europe. A cutting-edge pharmaceutical manufacturing plant and a laboratory with the highest-quality equipment are among the manufacturing facilities. The production lines and laboratories follow European standards, and a team of competent personnel ensures that these guidelines are followed. The manufacturing procedures meet all GMP regulations, whereas clinical trial goods are made per GLP and GMP principles.